(Q57212874)

English

Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-dail

scholarly article by Weiping Jia et al published April 2015 in The Lancet: Diabetes & Endocrinology

Statements

Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-dail (English)
0 references
Weiping Jia
0 references
Xinhua Xiao
0 references
Qiuhe Ji
0 references
Kyu-Jeung Ahn
0 references
Yuqian Bao
0 references
Can Pang
0 references
Lei Chen
0 references
Fei Gao
0 references
Yinfang Tu
0 references
Pengfei Li
0 references
Jun Yang
0 references
April 2015
0 references
3
0 references
4
0 references
254-62
0 references
254-262
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit